id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-N-3271-0002,FDA,FDA-2024-N-3271,Flamingo Pharmaceuticals Ltd.; Withdrawal of Approval of Two Abbreviated New Drug Applications,Notice,Withdrawal,2024-12-31T05:00:00Z,2024,12,2024-12-31T05:00:00Z,,2024-12-31T14:36:36Z,2024-31360,0,0,0900006486896c82
FDA-2024-N-3271-0001,FDA,FDA-2024-N-3271,Flamingo Pharmaceuticals Ltd.; Proposal To Withdraw Approval of Two Abbreviated New Drug Applications; Opportunity for a Hearing,Notice,Withdrawal,2024-08-08T04:00:00Z,2024,8,2024-08-08T04:00:00Z,2024-10-08T03:59:59Z,2024-08-08T17:09:56Z,2024-17515,0,0,090000648662587f